CVS director Mike Mahoney, whose day job is CEO of Boston Scientific, bought 30,000 shares of the healthcare company.
Shares of diversified healthcare company CVS Health (NYSE:CVS) jumped 16.4% in the morning session after the company reported ...
CNBC on MSN14d
CVS shares pop 15% on big earnings beat, even as high medical costs drag down insurance unitIt caps off the first full quarter with David Joyner, a longtime CVS executive, as CEO of the troubled retail drugstore chain. Joyner succeeded Karen Lynch in mid-October, as CVS struggled to drive ...
Hosted on MSN2mon
CVS accused of billing the U.S. for illegal opioid prescriptionsThe DOJ accuses CVS of filling illegal opioid prescriptions ... That’ll do it for your Daily Briefing. From the New York Stock Exchange, I’m Conway Gittens with TheStreet.
CVS Health Corp (NYSE:CVS) reported fourth-quarter sales of $97.71 billion, beating the consensus of $97.19 billion. Total ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results